Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Prostate Cancer

  Free Subscription


1 AJR Am J Roentgenol
5 BJU Int
1 Clin Cancer Res
1 Endocrinology
2 Eur Urol
1 Int J Cancer
1 J Clin Oncol
1 J Magn Reson Imaging
1 J Nucl Med
13 J Urol
2 Lancet Oncol
1 Magn Reson Imaging
1 Nat Rev Urol
1 Oncogene
1 PLoS One
3 Prostate
1 Urol Int
1 Urology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    AJR Am J Roentgenol

  1. GREER MD, Shih JH, Lay N, Barrett T, et al
    Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.
    AJR Am J Roentgenol. 2019 Mar 27:1-8. doi: 10.2214/AJR.18.20536.
    PubMed     Text format     Abstract available

    BJU Int

  2. KADONO Y, Nohara T, Kawaguchi S, Naito R, et al
    Investigating the mechanism underlying urinary continence recovery after radical prostatectomy: effectiveness of a longer urethral stump to prevent urinary incontinence.
    BJU Int. 2018;122:456-462.
    PubMed     Text format     Abstract available

  3. CHANDAK P, Byrne N, Lynch H, Allen C, et al
    Three-dimensional printing in robot-assisted radical prostatectomy - an Idea, Development, Exploration, Assessment, Long-term follow-up (IDEAL) Phase 2a study.
    BJU Int. 2018;122:360-361.
    PubMed     Text format    

  4. OXLEY J, Bray A, Rowe E
    Could a Mohs technique make NeuroSAFE a viable option?
    BJU Int. 2018;122:358-359.
    PubMed     Text format    

  5. KAOUK JH, Sagalovich D, Garisto J
    Robot-assisted transvesical partial prostatectomy using a purpose-built single-port robotic system.
    BJU Int. 2018;122:520-524.
    PubMed     Text format     Abstract available

  6. CHANG KD, Abdel Raheem A, Choi YD, Chung BH, et al
    Retzius-sparing robot-assisted radical prostatectomy using the Revo-i robotic surgical system: surgical technique and results of the first human trial.
    BJU Int. 2018;122:441-448.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  7. KREGEL S, Malik R, Asangani IA, Wilder-Romans K, et al
    Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration Resistant Prostate Cancer.
    Clin Cancer Res. 2019 Mar 27. pii: 1078-0432.CCR-18-3776.
    PubMed     Text format     Abstract available


  8. YANG C, Shen X, Ma R, Liu X, et al
    Letter to the Editor: "Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer".
    Endocrinology. 2019 Mar 28. pii: 5421009. doi: 10.1210/en.2019-00138.
    PubMed     Text format     Abstract available

    Eur Urol

  9. LI Y, Xie N, Chen R, Lee AR, et al
    RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.
    Eur Urol. 2019 Mar 22. pii: S0302-2838(19)30197.
    PubMed     Text format     Abstract available

  10. URABE F, Ochiya T, Egawa S
    Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
    Eur Urol. 2019 Mar 21. pii: S0302-2838(19)30183.
    PubMed     Text format    

    Int J Cancer

  11. FREDSOE J, Rasmussen AKI, Mouritzen P, Borre M, et al
    A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
    Int J Cancer. 2019 Mar 23. doi: 10.1002/ijc.32296.
    PubMed     Text format     Abstract available

    J Clin Oncol

  12. SKOLARUS TA, Metreger T, Wittmann D, Hwang S, et al
    Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial.
    J Clin Oncol. 2019 Mar 29:JCO1801770. doi: 10.1200/JCO.18.01770.
    PubMed     Text format     Abstract available

    J Magn Reson Imaging

  13. MERISAARI H, Jambor I, Ettala O, Bostrom PJ, et al
    IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy.
    J Magn Reson Imaging. 2019 Mar 22. doi: 10.1002/jmri.26727.
    PubMed     Text format     Abstract available

    J Nucl Med

  14. SOEDA F, Watabe T, Naka S, Liu Y, et al
    Impact of (18)F-PSMA-1007 uptake in prostate cancer using different peptide concentrations: preclinical PET/CT study in mice.
    J Nucl Med. 2019 Mar 22. pii: jnumed.118.223479. doi: 10.2967/jnumed.118.223479.
    PubMed     Text format     Abstract available

    J Urol

    Editorial Comment.
    J Urol. 2018;200:580.
    PubMed     Text format    

  16. LUDVIGSON A, Sammon J
    Editorial Comment.
    J Urol. 2018;200:581.
    PubMed     Text format    

  17. MARKS LS
    Editorial Comment.
    J Urol. 2018;200:563.
    PubMed     Text format    

  18. BOEHM K
    Editorial Comment.
    J Urol. 2018;200:557.
    PubMed     Text format    

  19. WANG S, Siddiqui MM
    Editorial Comment.
    J Urol. 2019;201:509.
    PubMed     Text format    

  20. ATALA A
    Re: Alterations of Tumor Microenvironment by Nitric Oxide Impedes Castration-Resistant Prostate Cancer Growth.
    J Urol. 2019 Mar 29:101097JU0000000000000251. doi: 10.1097/JU.0000000000000251.
    PubMed     Text format    

    Re: Risk of Prostate Cancer in Men Treated with 5alpha-Reductase Inhibitors-A Large Population-Based Prospective Study.
    J Urol. 2019 Mar 29:10109701JU00005577312536940.
    PubMed     Text format    

  22. ATALA A
    Re: Targeting FOXA1-Mediated Repression of TGF-beta Signaling Suppresses Castration-Resistant Prostate Cancer Progression.
    J Urol. 2019 Mar 29:10109701JU000055773048240.
    PubMed     Text format    

  23. PAK S, Park SY, Shin TJ, You D, et al
    Association of muscle mass with survival after radical prostatectomy in patients with prostate cancer.
    J Urol. 2019 Mar 27:101097JU0000000000000249. doi: 10.1097/JU.0000000000000249.
    PubMed     Text format     Abstract available

    Editorial Comment.
    J Urol. 2019;201:540.
    PubMed     Text format    

  25. MORASH C
    Editorial Comment.
    J Urol. 2019;201:527.
    PubMed     Text format    

  26. ABDI H, Breau RH
    Editorial Comment.
    J Urol. 2019;201:518.
    PubMed     Text format    

  27. BARR RG
    Editorial Comment.
    J Urol. 2018;200:557-558.
    PubMed     Text format    

    Lancet Oncol

  28. GOURD E
    New prognostic model for prostate cancer.
    Lancet Oncol. 2019 Mar 22. pii: S1470-2045(19)30185.
    PubMed     Text format    

  29. DAS M
    Preference-based intervention in prostate cancer.
    Lancet Oncol. 2019 Mar 22. pii: S1470-2045(19)30186.
    PubMed     Text format    

    Magn Reson Imaging

  30. WANG Y, Yu B, Zhong F, Guo Q, et al
    MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Magn Reson Imaging. 2019 Mar 24. pii: S0730-725X(18)30561.
    PubMed     Text format     Abstract available

    Nat Rev Urol

  31. LEBASTCHI AH, Pinto PA
    The role of multiparametric MRI in biopsy-naive prostate cancer.
    Nat Rev Urol. 2019 Mar 26. pii: 10.1038/s41585-019-0173.
    PubMed     Text format    


  32. SESHACHARYULU P, Rachagani S, Muniyan S, Siddiqui JA, et al
    FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.
    Oncogene. 2019 Mar 26. pii: 10.1038/s41388-019-0791.
    PubMed     Text format     Abstract available

    PLoS One

  33. DE SILVA D, Ranasinghe W, Bandaragoda T, Adikari A, et al
    Machine learning to support social media empowered patients in cancer care and cancer treatment decisions.
    PLoS One. 2018;13:e0205855.
    PubMed     Text format     Abstract available


  34. MILLIRON BJ, Bruneau M, Obeid E, Gross L, et al
    Diet assessment among men undergoing genetic counseling and genetic testing for inherited prostate cancer: Exploring a teachable moment to support diet intervention.
    Prostate. 2019 Mar 24. doi: 10.1002/pros.23783.
    PubMed     Text format     Abstract available

  35. KRZYZANOWSKA A, Don-Doncow N, Marginean FE, Gaber A, et al
    Expression of tSTAT3, pSTAT3(727) , and pSTAT3 (705) in the epithelial cells of hormone-naive prostate cancer.
    Prostate. 2019 Mar 24. doi: 10.1002/pros.23787.
    PubMed     Text format     Abstract available

  36. KRISTIANSEN A, Bergstrom R, Delahunt B, Samaratunga H, et al
    Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer.
    Prostate. 2019 Mar 25. doi: 10.1002/pros.23797.
    PubMed     Text format     Abstract available

    Urol Int

  37. BORKOWETZ A, Renner T, Platzek I, Toma M, et al
    Evaluation of Transperineal Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Compared to Transrectal Systematic Biopsy in the Prediction of Tumour Aggressiveness in Patients with Previously Negative Biopsy.
    Urol Int. 2019;102:20-26.
    PubMed     Text format     Abstract available


  38. FREITAS D, Andriole GL, Freedland SJ, Neto BS, et al
    Baseline basal cell hyperplasia is not associated with baseline lower urinary tract symptoms, baseline clinical prostatitis or prostate cancer in repeat biopsies.
    Urology. 2019 Mar 23. pii: S0090-4295(19)30312.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.